← Leaderboards
Joan L Walker
University Of Oklahoma Hlth Sciences Ctr
$454,198
Attributed
$454,198
Total exposure
6
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $378.7K · FY2005–06$500K$375K$250K$125K$0
'05
'06
Funding mix
By agency
NIH$454,198 · 6
By mechanism
M01$454,198 · 6
Top collaborators
No co-investigators on record.
Most similar at University Of Oklahoma Hlth Sciences Ctr
Same institution · by research overlap
- Robert S Mannel$9,366,958
- Doris Mangiaracina Benbrook$6,963,868
- Howard Ozer$1,086,241
- Kar-Ming Fung$3,379,440
- Wade Williams$1,475,300
Others in their field
Top investigators on “Neoplasm /Cancer Diagnosis”
- Bruce J Hillman · American College Of Radiology$89,322,170
- Edward J Benz · Dana-Farber Cancer Institute$55,517,478
- Leland H Hartwell · Fred Hutchinson Cancer Research Center$52,491,973
- Charles A Coltman · Southwest Oncology Group$50,842,631
- Philip J Disaia · University Of California Irvine$41,530,194
- Samuel A Wells · Duke University$32,148,803
Research focus
Neoplasm /Cancer DiagnosisHuman SubjectClinical ResearchWomen'S HealthPatient Oriented ResearchFemaleDiagnosis Design /EvaluationCervix NeoplasmsHuman PapillomavirusVirus Related Neoplasm /CancerPreneoplastic StateFemale Reproductive System Disorder DiagnosisCommunicable Disease DiagnosisBiopsyEndoscopyPrognosisCervix DisorderBiomarkerNeoplastic ProcessOpticsOvary NeoplasmsReproductive System InfectionSexually Transmitted DiseasesSign /Symptom
Grant awards (10)
EXPRESSION OF MN PROTEIN IN AGCUS AS POTENTIAL BIOMARKER OF DYSPLASIA/NEOPLASIA$462
M01 · FY2006 · RR · contact PI
A STUDY TO UNDERSTAND CERVICAL CANCER EARLY ENDPOINTS AND DETERMINANTS (SUCCEED)$188,306
M01 · FY2005 · RR
OUTCOMES IN GYNECOLOGIC CANCER$141,229
M01 · FY2005 · RR
PREVALENCE OF SYMPTOMS SUGGESTIVE OF OVARIAN CANCER$48,108
M01 · FY2005 · RR
EXPRESSION OF MN PROTEIN IN AGCUS AS POTENTIAL BIOMARKER OF DYSPLASIA/NEOPLASIA$1,031
M01 · FY2005 · RR
Study to Understand Cervical Cancer Early Endpoints an$43,536
M01 · FY2004 · RR
Outcomes in Gynecologic Cancer$27,773
M01 · FY2004 · RR
Pivotal Study II: Single-Arm Multi-Ctr. Study of ODS as Adjunct to Colposcopy$2,627
M01 · FY2004 · RR
Prevalence of Symptoms Suggestive of Ovarian Cancer$751
M01 · FY2004 · RR
Expression of MN Protein in AGCUS as Potential Biomarker of Dysplasia/Neoplasia$375
M01 · FY2004 · RR